StockClub

AVIR

AVIRAtea Pharmaceuticals, Inc.$ --
Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals, Inc.

AVIR

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
0M USD
YoY -
Operating Income
-55M USD
YoY -40.8%
Net Income
-45M USD
YoY -33.8%
EPS
-0.57$
YoY -42.5%

Revenue

$0
FY2024 Q1$0
$0
Q1
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
Actual
$0 (-)

Net Income

$-158.3M
FY2024 Q1$-63.2M
$-63.2M
Q1
FY2024 Q2$-103.7M
$-103.7M
Q2
FY2024 Q3$-134.8M
$-134.8M
Q3
FY2024 Q4$-168.4M
$-168.4M
Q4
FY2025 Q1$-34.3M
$-34.3M
Q1
FY2025 Q2$-71.4M
$-71.4M
Q2
FY2025 Q3$-113.5M
$-113.5M
Q3
FY2025 Q4$-158.3M
$-158.3M
Q4
Actual
+$10M (+6.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$48.6M
Est:$163M
FY2020MISS
$48.6M
FY2021BEAT
Actual:$351.4M
Est:$259M
FY2021BEAT
$351.4M
FY2022MISS
Actual:$0
Est:$241M
FY2022MISS
$0
FY2023
Actual:$0
FY2023
$0
FY2024MISS
Actual:$0
Est:$68.3M
FY2024MISS
$0
FY2025MISS
Actual:$0
Est:$7.1M
FY2025MISS
$0

Analyst Estimates